Newsroom

LRG & Collaborators Publish New Paper on Adjuvant Imatinib in KIT Exon 9 Mutations

Published on February 26, 2026, this international study represents a major collaboration between The Life Raft Group and thirty-five leading cancer centers across the U.S., Europe, and Japan to better understand treatment for gastrointestinal stromal tumors (GIST) with KIT exon 9 mutations.

By |2026-03-05T15:27:13-05:00March 4th, 2026|News, Research|

Patient & Caregiver of the Month for February – Carolyn & Mark Dewalt

Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Carolyn & Mark shares their story.

Go to Top